Inozyme Pharma INZY
$ 2.71
-2.87%
Quarterly report 2024-Q3
added 11-05-2024
Inozyme Pharma Income Statement 2011-2024 | INZY
Annual Income Statement Inozyme Pharma
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
297 M | 102 M | 161 M | 381 M | - | - | - | - | - | - | - | - | - |
Shares |
51.8 M | 37.8 M | 23.6 M | 18.1 M | - | - | - | - | - | - | - | - | - |
Historical Prices |
5.72 | 2.69 | 6.82 | 20.6 | - | - | - | - | - | - | - | - | - |
Net Income |
-71.2 M | -67.1 M | -56.6 M | -56.4 M | -19.7 M | -6.96 M | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-75.6 M | -68.7 M | -56.6 M | -57 M | -20.8 M | - | - | - | - | - | - | - | - |
Interest Expense |
3.33 M | 262 K | -189 K | 247 K | -24 K | - | - | - | - | - | - | - | - |
EBITDA |
-74.8 M | -68 M | -56 M | -56.8 M | -20.7 M | -11.6 M | - | - | - | - | - | - | - |
Operating Expenses |
75.6 M | 68.7 M | 56.6 M | 57 M | 20.8 M | 11.6 M | - | - | - | - | - | - | - |
General and Administrative Expenses |
20.8 M | 20.8 M | 18.9 M | 10.5 M | 4.59 M | 3.49 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Inozyme Pharma
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
63.3 M | 61.9 M | 61.8 M | 61.8 M | 56.8 M | 44.9 M | 43.7 M | 40.4 M | 43.7 M | 39.7 M | 23.7 M | 23.7 M | 23.6 M | 23.5 M | 23.4 M | 23.4 M | 18.1 M | 1.25 M | 1.21 M | 1.2 M | 1.2 M | 1.17 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-24.6 M | -27 M | -23.3 M | - | -16.6 M | -15.6 M | -17.4 M | - | -16.4 M | -15.3 M | -16.9 M | - | -14.3 M | -12.5 M | -11 M | - | 56.4 M | -56.4 M | -56.4 M | - | -19.7 M | -19.7 M | -4.97 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-24.9 M | -27.7 M | -24.3 M | - | -18.1 M | -16.4 M | -18.4 M | - | -16.9 M | -15.4 M | -16.8 M | - | -14.3 M | -12.7 M | -11 M | - | -28.3 M | -9.55 M | -7.91 M | - | -4.32 M | -4.55 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
-81 K | 1.4 M | 1.32 M | - | 20 K | 771 K | 328 K | - | -197 K | -191 K | -105 K | - | -65 K | 57 K | -141 K | - | 157 K | 4 K | -3 K | - | -3 K | -14 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | -24.2 M | - | - | - | -18.2 M | - | -16.7 M | -15.2 M | -16.7 M | - | -14.1 M | -12.5 M | -10.8 M | - | -28.3 M | -9.52 M | -7.88 M | - | -4.3 M | -4.53 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
24.9 M | 27.7 M | 24.3 M | - | 18.1 M | 16.4 M | 18.4 M | - | 16.9 M | 15.4 M | 16.8 M | - | 14.3 M | 12.7 M | 11 M | - | 28.3 M | 9.55 M | 7.91 M | - | 4.32 M | 4.55 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
4.96 M | 5.91 M | 5.23 M | - | 4.73 M | 4.73 M | 6.51 M | - | 4.72 M | 5.38 M | 5.02 M | - | 4.92 M | 4.44 M | 4.37 M | - | 3.14 M | 1.67 M | 1.5 M | - | 1 M | 1.06 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency